Published in
American Association for the Advancement of Science, Science Translational Medicine, 396(9), 2017
DOI: 10.1126/scitranslmed.aak9969
Links
- ORCID
- ORCID
- American Association for the Advancement of Science
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [infoscience.epfl.ch] | PDF
Tools
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma
Journal article published in 2017 by
Elisa Oricchio 
,
Natalya Katanayeva ,
Maria Christine Donaldson ,
Stephanie Sungalee ,
Joyce P. Pasion ,
Wendy Béguelin,
Elena Battistello ,
Viraj R. Sanghvi,
Man Jiang ,
Yanwen Jiang,
Matt Teater ,
Anita Parmigiani ,
Andrei V. Budanov ,
Fong Chun Chan,
Sohrab P. Shah
and other authors.
,
Natalya Katanayeva ,
Maria Christine Donaldson ,
Stephanie Sungalee ,
Joyce P. Pasion ,
Wendy Béguelin,
Elena Battistello ,
Viraj R. Sanghvi,
Man Jiang ,
Yanwen Jiang,
Matt Teater ,
Anita Parmigiani ,
Andrei V. Budanov ,
Fong Chun Chan,
Sohrab P. Shah
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
SESTRIN1 is a tumor suppressor deleted or epigenetically silenced by mutated EZH2.